Trademark: RETHINK ADHD SYMPTOM CONTROL
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
RETHINK ADHD SYMPTOM CONTROL
Click here to search for trademarks similar to RETHINK ADHD SYMPTOM CONTROL
Proof of use for RETHINK ADHD SYMPTOM CONTROL
We do not have any records of a proof of use for RETHINK ADHD SYMPTOM CONTROL at this moment.
Click here to add a proof of use for RETHINK ADHD SYMPTOM CONTROL
Possible trademark infringements of RETHINK ADHD SYMPTOM CONTROL
Basic Information about RETHINK ADHD SYMPTOM CONTROL
- Serial Number
- 90287870
- Filing Date
- 29 Oct 2020
- Registration Number
- 6668162
- Registration Date
- 08 Mar 2022
- Mark Drawing Code
- 5
Classifications
Declare the trademark use of RETHINK ADHD SYMPTOM CONTROL on the blockchain with WikiTrademarks.io.
- First use of RETHINK ADHD SYMPTOM CONTROL anywhere
- RETHINK ADHD SYMPTOM CONTROL was first used on 25 May 2021 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns RETHINK ADHD SYMPTOM CONTROL?
1. Supernus Pharmaceuticals, Inc. Rockville MD
2. Supernus Pharmaceuticals, Inc. Rockville MD
3. Supernus Pharmaceuticals, Inc. Rockville MD
Correspondent
- Mark Simpson
- SAUL EWING ARNSTEIN & LEHR
- 1500 MARKET STREET
- CENTRE SQUARE WEST, 38TH FLOOR
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io